Clinical trials
Pulmonary Emphysema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 10 |
| Unknown status | 7 |
| Recruiting | 6 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aeris Therapeutics | 13 |
| Grifols Therapeutics LLC | 6 |
| Heidelberg University | 3 |
| Pulmonx Corporation | 3 |
| Royal Brompton & Harefield NHS Foundation Trust | 3 |
| Mansoura University | 2 |
| Olympus Corporation of the Americas | 2 |
| University Hospital, Rouen | 2 |
| Asan Medical Center | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Emphysema | 64 |
| Pulmonary Disease, Chronic Obstructive | 42 |
| Emphysema | 28 |
| Lung Diseases | 18 |
| Respiratory Tract Diseases | 13 |
| Bronchitis, Chronic | 9 |
| Lung Diseases, Obstructive | 8 |
| Pathologic Processes | 7 |
| alpha 1-Antitrypsin Deficiency | 7 |
| Respiratory Aspiration | 4 |
Trials
Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.